Article
Lynch syndrome - cancer pathways, heterogeneity and immune escape.
The Journal of pathology - 1 Oct 2018
Seth Sidhant, Ager Ann, Arends Mark J, Frayling Ian M
Abstract excerpt
Recent work has provided evidence for genetic and molecular heterogeneity in colorectal cancers (CRCs) arising in patients with Lynch syndrome (LS), dividing these into two groups: G1 and G2. In terms of mutation and gene expression profile, G1 CRCs bear resemblance to sporadic CRCs with microsatellite instability (MSI), whereas G2 CRCs are more similar to microsatellite-stable CRCs. Here we review the current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
